David Kabakoff - Profile and Investment Details

Investor Profile

David Kabakoff is a Venture Capital, Private Equity Firm, Investor based in Rancho Santa Fe, California, United States with a diverse investment portfolio that includes companies such as Magnolia Medical Technologies, Avizia, RareCyte, inMediata, Bardy Diagnostics, Springbuk, Spirox, Alcresta, Pulmonx, Vestagen Technical Textiles, Harmony Home Health, Venus Concept, Biotheranostics, Trice Medical, Trius Therapeutics, Lineagen, First Aid Shot TherapyEverlyWell, Dauntless Pharmaceuticals, Perspectum, CleanSlate Centers, Ajax Health, Castle Biosciences, TigerConnect, BioIQ, Avedro, . Over time, David Kabakoff has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether David Kabakoff is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Cybersecurity, Messaging, Wellness, Women Founded, Enterprise Software, Mobile, Biotechnology, Consumer Health, Cosmetics, Electronic Health Records (EHR), Health and Hospital Services, Productivity Software, Legal Tech, Clinical Trials, Natural Language Processing, Health Diagnostics, Digital Health, Medical, Pharmaceuticals may find it worthwhile to explore potential connections with David Kabakoff, as their portfolio suggests a familiarity and interest in this area.

Understanding David Kabakoff’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.